Y. Miyazaki et al., FGR PROTOONCOGENE IS EXPRESSED DURING TERMINAL GRANULOCYTIC DIFFERENTIATION OF HUMAN PROMYELOCYTIC HL-60 CELLS, Experimental hematology, 21(2), 1993, pp. 366-371
In order to elucidate the function of the c-fgr protein tyrosien kinas
e, we have investigated the expression of c-fgr in the human promyeloc
ytic cell line, HL60, during myeloid differentiation induced by dimeth
ylsulfoxide (DMSO). The expression of c-fgr was preceded by growth arr
est of DMSO-treated cells, as determined by [H-3]-thymidine incorporat
ion and colony-forming ability, and it became detectable when cells co
mmitted for terminal differentiation. The maximum expression was detec
ted in the terminal stage of differentiation. The profile of tyrosine
phosphorylation in cellular proteins was distinct among cells at vario
us stages of the differentiation program. The 116 kd tyrosine-phosphor
ylated protein detected in exponentially proliferating HL60 cells dimi
nished during the course of the growth arrest and a distinct profile o
f tyrosine phosphorylation (including 177 and 165 kd proteins) appeare
d in cells undergoing terminal granulocytic differentiation. These fin
dings implicate the involvement of p55(c-fgr) in the process of termin
al granulocytic differentiation. However, the tyrosine kinase activity
of p55(c-frg) expressed in differentiating HL60 cells was markedly in
hibited by the tyrosine phosphatase inhibitor, sodium orthovanadate, s
uggesting the presence of a mechanism involving tyrosine phosphorylati
on that negatively regulates the kinase activity of p55(c-fgr).